Baclofen for maintenance treatment of opioid dependence: A randomised double-blind placebo-controlled clinical trial

Completed

• Conditions: Opioid dependence; Mental and Behavioural Disorders; Drug addiction

• Registration Number: ISRCTN32121581
• Lead Sponsor: Roozbeh Addiction Department (Iran)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2003-11-17
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

Subjects were eligible for the study if they:
1. Met DSM-IV criteria for opioid dependence
2. Were detoxified at our addiction clinic
3. Were between 18 and 60 years of age
4. Gave written informed consent for participation in the study

Opioid dependence (according to Diagnostic and Statistical Manual of Mental Disorders, fourth edition [DSM-IV] criteria).

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified